Physician profile
Marcella Bramblett
NPI 1720477086
$844.43
in general payments reported to CMS, 2019-2025
15 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $147 · 2023: $293 · 2024: $73.23 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.08 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $250.64 | 2023-2025 | Interstim, Nuro |
| Amgen INC. | $104.08 | 2021-2024 | Prolia, Evenity |
| Exeltis, USA INC. | $73.34 | 2021-2022 | |
| Astellas Pharma US INC | $72.99 | 2023 | |
| Abbvie INC. | $61.21 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $58.52 | 2023 | Myfembree |
| Boston Scientific Corporation | $36.05 | 2025 | Axonics |
| Organon LLC | $33.83 | 2021-2022 | |
| Janssen Biotech, INC. | $31.30 | 2023 | Erleada, Akeega |
| Rhythm Pharmaceuticals, INC. | $26.47 | 2025 | Imcivree |
| Hologic Sales and Service, LLC | $22.78 | 2025 | Aptima |
| Myriad Genetic Laboratories, INC. | $21.66 | 2023 | Prolaris |
| Myovant Sciences INC. | $18.56 | 2022 | |
| Axonics, INC. | $16.85 | 2021 | |
| Daiichi Sankyo INC. | $16.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcella Bramblett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.